{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System - GN Meropenem-vaborbactam (0.125/8-32/8 \u03bcg/mL)"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K173523",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "February 9, 2018",
    "Summary Letter Received Date": "November 14, 2017",
    "Submission Date": "November 10, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Meropenem-vaborbactam"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution",
        "Automated susceptibility testing",
        "Redox indicator-based growth detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimum inhibitory concentration determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System - GN Meropenem-vaborbactam for automated antimicrobial susceptibility testing of Gram-negative bacteria.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by MIC of Gram-negative aerobic and facultative anaerobic bacteria (Enterobacteriaceae, Non-Enterobacteriaceae) and most Gram-positive isolates from pure culture for specified genera.",
    "fda_folder": "Microbiology"
}